Seino Y

References (3)

Title : A Randomized, Placebo-controlled Study to Evaluate the Efficacy and Safety of Adding Omarigliptin to Insulin Therapy in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control - Kadowaki_2021_Diabetes.Obes.Metab__
Author(s) : Kadowaki T , Seino Y , Kaku K , Okamoto T , Kameya M , Sato A , Hirano T , Oshima N , Gantz I , O'Neill EA , Engel SS
Ref : Diabetes Obes Metab , : , 2021
Abstract : Kadowaki_2021_Diabetes.Obes.Metab__
ESTHER : Kadowaki_2021_Diabetes.Obes.Metab__
PubMedSearch : Kadowaki_2021_Diabetes.Obes.Metab__
PubMedID: 33512755

Title : Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes - Omar_2014_Diabetologia_57_1876
Author(s) : Omar BA , Liehua L , Yamada Y , Seino Y , Marchetti P , Ahren B
Ref : Diabetologia , 57 :1876 , 2014
Abstract : Omar_2014_Diabetologia_57_1876
ESTHER : Omar_2014_Diabetologia_57_1876
PubMedSearch : Omar_2014_Diabetologia_57_1876
PubMedID: 24939431

Title : Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors - Hansotia_2004_Diabetes_53_1326
Author(s) : Hansotia T , Baggio LL , Delmeire D , Hinke SA , Yamada Y , Tsukiyama K , Seino Y , Holst JJ , Schuit F , Drucker DJ
Ref : Diabetes , 53 :1326 , 2004
Abstract : Hansotia_2004_Diabetes_53_1326
ESTHER : Hansotia_2004_Diabetes_53_1326
PubMedSearch : Hansotia_2004_Diabetes_53_1326
PubMedID: 15111503